Regli Adrian, Becke Karin, von Ungern-Sternberg Britta S
aDepartment of Intensive Care, Fiona Stanley Hospital, Murdoch bSchool of Medicine and Pharmacology, The University of Western Australia cSchool of Medicine, The University of Notre Dame, Perth, Western Australia, Australia dDepartment of Anesthesia and Intensive Care, Klinik Hallerwiese, Cnopf'sche Kinderklinik, Nuernberg, Germany eDepartment of Anesthesia and Pain Management, Princess Margaret Hospital for Children, Subiaco fSchool of Medicine and Pharmacology, The University of Western Australia, Perth, Western Australia, Australia.
Curr Opin Anaesthesiol. 2017 Jun;30(3):362-367. doi: 10.1097/ACO.0000000000000460.
This review summarizes the current evidence for the management of children with recent upper respiratory tract infections (URTIs). Furthermore, the review includes management guidelines for children with URTIs.
Good history and clinical examination is sufficient in most children presenting with URTI. Testing for immune markers or preoperative nitric oxide measurement does not add any additional value. Preoperative bronchodilator administration, intravenous induction with propofol, and noninvasive airway management all reduce the occurrence of respiratory adverse events.
Most children can be safely anaesthetized even in the presence of an URTIs if the perioperative anaesthesia management is optimized. In this review article, we have included a management algorithm for children with URTI presenting for elective surgery.
本综述总结了近期上呼吸道感染(URTIs)患儿管理的当前证据。此外,该综述还包括URTIs患儿的管理指南。
对于大多数出现URTIs的患儿,详细的病史和临床检查就足够了。检测免疫标志物或术前一氧化氮测量并无额外价值。术前给予支气管扩张剂、丙泊酚静脉诱导和无创气道管理均可减少呼吸不良事件的发生。
如果围手术期麻醉管理得到优化,即使存在URTIs,大多数患儿也可安全进行麻醉。在这篇综述文章中,我们纳入了择期手术的URTIs患儿的管理流程。